Published in Drugs Aging on January 01, 2006
Patient and caregiver quality of life in Huntington's disease. Mov Disord (2008) 1.29
Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial. BMC Geriatr (2008) 1.05
Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord (2010) 1.01
The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis. J Neural Transm (Vienna) (2013) 0.99
Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans. Health Qual Life Outcomes (2010) 0.95
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. J Neurol (2011) 0.93
The health-related, social, and economic consequences of parkinsonism: a controlled national study. J Neurol (2011) 0.87
Herbal medicines for Parkinson's disease: a systematic review of randomized controlled trials. PLoS One (2012) 0.82
Health-related quality of life and strain in caregivers of Australians with Parkinson's disease: an observational study. BMC Neurol (2012) 0.82
Progression of voice and speech impairment in the course of Parkinson's disease: a longitudinal study. Parkinsons Dis (2013) 0.81
A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment. PLoS One (2014) 0.81
Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias. J Neural Transm (Vienna) (2012) 0.81
Lack of information and access to advanced treatment for Parkinson's disease patients. J Multidiscip Healthc (2011) 0.81
Loss of ability to work and ability to live independently in Parkinson's disease. Parkinsonism Relat Disord (2011) 0.78
Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial. Trials (2013) 0.75
National surveys: a way to manage treatment strategies in Parkinson's disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease. J Multidiscip Healthc (2013) 0.75
Do neurologists in Germany adhere to the national Parkinson's disease guideline? Neuropsychiatr Dis Treat (2011) 0.75
Successful use of rasagiline in combination with two antidepressants: a case report. Innov Clin Neurosci (2012) 0.75
Determinants of generic and specific health-related quality of life in patients with Parkinson's disease. PLoS One (2017) 0.75
Measuring family impact of skin diseases: FDLQI and FROM-16. Acta Derm Venereol (2015) 1.38
Equivalence of electronic and paper-based patient-reported outcome measures. Qual Life Res (2015) 0.97
The development and validation of the major life changing decision profile (MLCDP). Health Qual Life Outcomes (2013) 0.81
Impairment of Sexual Life in 3,485 Dermatological Outpatients From a Multicentre Study in 13 European Countries. Acta Derm Venereol (2016) 0.75
Attachment Styles of Dermatological Patients in Europe: A Multi-centre Study in 13 Countries. Acta Derm Venereol (2017) 0.75
Determinants of Psychosocial Health in Psoriatic Patients: A Multi-national Study. Acta Derm Venereol (2017) 0.75